# Alexis Du Peloux

> Alexis Du Peloux is a seed investor at XAnge backing Cyber Security and Artificial Intelligence. See 9 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [XAnge](https://shizune.co/investors/profile/xange-private-equity)
- Location: Paris, France
- Total investments: 9
- Last investment: Mar 2025
- Lead investor: 44%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/alexis-du-peloux-de-saint-romain-3227b820/

Alexis Du Peloux is a seed investor at XAnge in Paris focused on Cyber Security and Artificial Intelligence. Alexis Du Peloux - Partner @ XAnge

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Cyber Security | 2 | 22% |
| Artificial Intelligence | 2 | 22% |
| SaaS | 1 | 11% |
| FinTech | 1 | 11% |
| Software | 1 | 11% |

20 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 44% |
| Series A | 2 | 22% |
| Pre-Seed | 1 | 11% |
| Series B | 1 | 11% |
| Venture - Series Unknown | 1 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Tomorro | Tomorro is an AI-driven contract lifecycle management platform that automates the processes of contract creation, negotiation, and approval. The platform streamlines workflows for sales teams by providing tools that enhance efficiency and accuracy in contract management. It offers features such as automated document generation, real-timecollaboration, and built-in compliance checks. Tomorro also includes an e-signature solution that facilitates the signing of contracts, ensuring a seamless experience for users. By integrating these functionalities, Tomorro aims to simplify the complexities of contract management for organizations. | $27M | Series B | Mar 31, 2025 |  |
| Request Finance | Request Finance provides a financial management platform for businesses to handle cryptocurrency invoicing, payroll, and expenses. The platform enables users to send and receive invoices in various cryptocurrencies, automate payments, and track financial transactions. It supports compliance with tax regulations and integrates with accountingsystems for streamlined reporting. Request Finance serves companies, freelancers, and DAOs by simplifying digital asset payments and financial operations. |  | Venture - Series Unknown | Mar 25, 2025 |  |
| Gladia | 1 stop shop AI API hub for developers | $15.9M | Series A | Oct 15, 2024 |  |
| Dattak | Dattak offers cyber insurance solutions based on cybersecurity technologies. Their cybersecurity tools allow us to assess a company's level of cybersecurity without complex questionnaires. They provide their policyholders with a variety of cybersecurity tools to help them prevent and defend against cyberattacks. | $12M | Series A | Aug 30, 2023 |  |
| elba | Elba interfaces with the SaaS ecosystem of its customers, finds security flaws, and alerts their teams to repair them with a single click. | $2.7M | Seed | Jun 06, 2023 |  |
| Dogami | Dogami is a mass-market NFT play-to-earn game that is centered around 3D NFT dog avatars. | $7M | Seed | Dec 13, 2022 |  |
| Request Finance | Request Finance provides a financial management platform for businesses to handle cryptocurrency invoicing, payroll, and expenses. The platform enables users to send and receive invoices in various cryptocurrencies, automate payments, and track financial transactions. It supports compliance with tax regulations and integrates with accountingsystems for streamlined reporting. Request Finance serves companies, freelancers, and DAOs by simplifying digital asset payments and financial operations. | $5.5M | Seed | Jun 08, 2022 |  |
| ROOF | Roof creates better housing solutions by designing and managing furnished, community-minded quality homes located in Top Student Cities. | $3.4M | Pre-Seed | Jan 01, 2022 |  |
| Epigene Labs | Over the past couple of decades, the exponential progress of sequencing technologies has allowed an increasing number of cancer patients to benefit from precision oncology. However, the aggregation, analysis, and visualization of the massive amounts of genomic data remain a major challenge for precision oncology expansion.The Epigene Labstechnology platform enables cancer drug hunters to seamlessly leverage advanced artificial intelligence in transforming genomic data into actionable insights for designing precision oncology approaches.With R&D in Paris and business development in Boston, Epigene Labs operates in the setting of value-based partnerships with world leading cancer centers and high-profile biotechs. | $1.5M | Seed | Jan 30, 2020 |  |

9 of 9 investments shown.

## Co-investors
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund, 6 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 3 deals together
- [Balderton Capital](https://shizune.co/investors/profile/balderton-capital) — VC Fund, 2 deals together
- [Founders Future](https://shizune.co/investors/profile/founders-future) — VC Fund, 2 deals together
- [Acton Capital](https://shizune.co/investors/profile/acton-capital-partners) — VC Fund, 1 deal together
- [Adelie](https://shizune.co/investors/profile/adelie-afcc) — VC Fund, 1 deal together

## About XAnge

VC Fund · Paris, France

XAnge is a Franco-German team of venture capital investors that manages €450 million and invests in digital, deeptech, and impact startups.It is the innovation brand of the Siparex group, a major player in French private equity. XAnge is a key European investor in early-stage startups and is looking for game-changing startups and entrepreneurswho rock the code[s].The Paris, Ile-de-France-located company was founded in 2004.

5 contacts available at XAnge.

| Name | Title | Profile |
| --- | --- | --- |
| Alexis Du Peloux | Partner | https://shizune.co/investors/profile/alexis-du-peloux |
| Cyril Bertrand | CEO & Managing Partner | https://shizune.co/investors/profile/cyril-bertrand |
| Guilhem De Vregille | Partner | https://shizune.co/investors/profile/guilhem-de-vregille |
| Andréas Gall | Partner | https://shizune.co/investors/profile/andr%C3%A9as-gall |
| Astrid Moullé-Berteaux | Associate | https://shizune.co/investors/profile/astrid-moull%C3%A9-berteaux |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Alexis Du Peloux invest in?

Alexis Du Peloux invests primarily in Cyber Security, Artificial Intelligence and SaaS startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Alexis Du Peloux last invest?

The most recent investment recorded for Alexis Du Peloux closed in Mar 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co